Impaired upregulation of keratinocyte growth factor in injured lungs induced by Pseudomonas aeruginosa in immunosuppressed rats

( views:89, downloads:0 )
XU Jin-fu()
QU Jie-ming()
HE Li-xian()
OU Zhou-luo()
Journal Title:
Volume 119, Issue 17, 2006
Key Word:
immunosuppression;Pseudomonas aeruginosa;pneumonia;lung injury;keratinocyte growth factor

Abstract: Background The number of immunosupressed patients has increased in the past decades. Among them Pseudomonas aeruginosa (P. aeruginosa) is one of the leading bacteria for pneumonia that are associated with poor prognosis. However, the pathogenesis of P. aeruginosa pneumonia in immunosupressed patients is not understood completely. Previous reports showed keratinocyte growth factor (KGF) is associated with lung injury in immunocompetent hosts. In this study, we investigated the different reactions of lung injury, lung pathology and KGF expressions in P. aeruginosa pneumonia between immunosuppressed and immunocompetent rats.Methods Immunosuppression of male rats was induced by injecting immunosuppressive subcutaneously.Pneumonia was established by instilling P. aeruginous tracheally. The immunocompetent rats were the control group. Survival rate, lung histopathology, pulmonary permeability and oedema, KGF mRNA and protein expressions in lungs of both groups were investigated.Results The survival rate of immunosuppressed group was lower than that of immunocompetent group (33.3%vs 83.3%). After exposure to bacteria, pulmonary permeability and wet/dry ratio in immunosuppressed group were higher than those in immunocompetent group. Pulmonary congestion and haemorrhage were more intensive in immunosuppressed group compared to immunocompetent group. Apoptosis and necrosis were also observed in infected lungs of immunosuppressed rats. Although we detected KGF expressions in lungs of both groups after infection, the expressions of KGF protein and mRNA gene in immunosuppressed group were much lower than in immunocompetent group.Conclusions Compared with immunocompetent group, there was more intensive lung injury in immunosuppressed group. Severe lung injury may contribute to the poor prognosis of pneumonia. KGF expressions of pneumonia in immunosuppressed rats were less than those in immunocompetent ones.

  • [1]Agusti C,Rano A,Sibila O,Torres A.Nosocomial pneumonia in immunosuppressed patients.Infect Dis Clin North Am 2003;17:785-800.
  • [2]Ognibene FP,Martin SE,Parker MM,Schlesinger T,Roach P,Burch C,et al.Adult respiratory distress syndrome in patients with severe neutropenia.N Engl J Med 1986; 315:547-551.
  • [3]Carratala J,Roson B,Fernandez-Sevilla A,Alcaide F,Gudiol F.Bacteremic pneumonia in neutropenic patients with cancer:causes,empirical antibiotic therapy,and outcome.Arch Intern Med 1998; 158:868-872.
  • [4]Cryz SJ Jr,Furer E,Germanier R.Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.Infect Immun 1983; 39:1067-1071.
  • [5]Azghani AO,Baker JW,Shetty S,Miller EJ,Bhat GJ.Pseudomonas aeruginosa elastase stimulates ERK signaling pathway and enhances IL-8 production by alveolar epithelial cells in culture.Inflamm Res 2002;51:506-510.
  • [6]Kang CI,Kim SH,Kim HB,Park SW,Choe YJ,Oh MD,et al.Pseudomonas aeruginosa bacteremia:risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.Clin Infect Dis 2003; 37:745-751.
  • [7]Siegman-lgra Y,Ravona R,Primerman H,Giladi M.Pseudomonas aeruginosa bacteremia:an analysis of 123 episodes,with particular emphasis on the effect of antibiotic therapy.Int J Infect Dis 1998; 2:211-215.
  • [8]Chelly N,Henrion A,Pinteur C,Chailley-Heu B,Bourbon JR.Role of KGF in the control of surfactant synthesis by fetal lung mesenchyme.Endocrinology 2001;142:1814-1819.
  • [9]Haddad IY,Milla C,Yang S,Panoskaltsis-Mortari A,Hawgood S,Lacey DL,et al.Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation.Am J Physiol Lung Cell Mol Physiol 2003;285:L602-610.
  • [10]Viget NB,Guery BPH,Ader F,Neviere R,Alfandari S,Creuzy C,et al.Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.Am J Physiol Lung Cell Mol Physiol 2000;279:L1199-1209.
  • [11]Lesprit P,Faurisson F,Join-Lambert O,Roudot-Thoraval F,Foglino M,Vissuzaine C,et al.Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats.Am J Respir Crit Care Med 2003; 167:1478-1482.
  • [12]Grassme H,Jendrossek V,Riehle A,von Kurthy G,Berger J,Schwarz H,et al.Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.Nat Med 2003;9:322-330.
  • [13]Dallaire F,Bergeron Y,Ouellet N,Turmel V,Gauthier MC,Simard M,et al.Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.J Infect Dis 2001 ;184:292-300.
  • [14]Fillion I,Ouellet N,Simard M,Bergeron Y,Sato S,Bergeron MG.Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.J Immunol 2001;166:7353-7361.
  • [15]Duly EB,Grimason S,Grimason P,Barnes G,Trinick TR.Measurement of serum albumin by capillary zone electrophoresis,bromocresol green,bromocresol purple,and immunoassay methods.J Clin Pathol 2003;56:780-781.
  • [16]Kao SJ,Wang D,Yeh DY,Hsu K,Hsu YH,Chen HI.Static Inflation Attenuates Ischemia/Reperfusion Injury in an Isolated Rat Lung In Situ.Chest 2004;126:552-558.
  • [17]Yano T,Mason RJ,Pan T,Deterding RR,Nielsen LD,Shannon JM.KGF regulates pulmonary epithelial proliferation and surfactant protein gene e xpression in adult rat lung.Am J Physiol Lung Cell Mol Physiol 2000;279:L1146-1158.
  • [18]Offidani M,Corvatta L,Malerba L,Marconi M,Bichisecchi E,Cecchini S,et al.Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates:a historical cohort study.Cancer 2004; 101:567-577.
  • [19]Duong M,Ouellet N,Simard M,Bergeron Y,Olivier M,Bergeron MG.Kinetic Study of Host Defense and Inflammatory Response to Aspergillus fumigatus in Steroid-Induced Immunosuppressed Mice.J Infect Dis 1998;178:1472-1482.
  • [20]Qu J,Li Z,He L.Inflammatory reaction and alterations of pulmonary surfactant in Pseudomonas Aeruginosa pneumonia in immunocompromised rats.Chin Med J 2002;115:1099-1100
  • [21]Kainulainen L,Nikoskelainen J,Ruuskanen O.Diagnostic findings in 95 Finnish patients with common variable immunodeficiency.J Clin Immunol 2001;21:145-149.
  • [22]Wang E,Simard M,Ouellet N,Bergeron Y,Beauchamp D,Bergeron MG.Pathogenesis of Pneumococcal Pneumonia in Cyclophosphamide-Induced Leukopenia in Mice.Infect Immun 2002;70:4226-4238.
  • [23]Patterson CE,Lum H.Update on pulmonary edema:the role and regulation of endothelial barrier function.Endothelium 2001 ;8:75-105.
  • [24]Menezes SL,Bozza PT,Neto HC,Laranjeira AP,Negri EM,Capelozzi VL,et al.Pulmonary and extrapulmonary acute lung injury:inflammatory and ultrastructural analyses.J Appl Physiol 2005;98:1777-1783.
  • [25]Verkman AS.Aquaporin water channels and endothelial cell function.J Anat 2002;200:617-627.
  • [26]Sakuma T,Okaniwa G,Nakada T,Nishimura T,Fujimura S,Matthay MA.Alveolar fluid clearance in the resected human lung.Am J Respir Crit Care Med 1994;150:305-310.
  • [27]Geiser T.Mechanisms of alveolar epithelial repair in acute lung injury-a translational approach.Swiss Med Wkly 2003; 133:586-590.
  • [28]Panos RJ,Rubin JS,Csaky KG,Aaronson SA,Mason RJ.Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type Ⅱ cells in fibroblast-conditioned medium.J Clin Invest 1993;92:969-977.
  • [29]Ray P,Devaux Y,Stolz DB,Yarlagadda M,Watkins SC,Lu Y,et al.Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia.Proc Natl Acad Sci USA 2003; 100:6098-6103.
  • [30]Atabai K,Ishigaki M,Geiser T,Ueki I,Matthay MA,Ware LB.Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms.Am J Physiol Lung Cell Mol Physiol 2002;283:L163-169.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615